Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
about
Performance of novel kidney biomarkers in preclinical toxicity studiesSecretome profiling with antibody microarrays.Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trialInhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis.Therapeutic potential of TGF-beta inhibition in chronic renal failure.Mechanisms of disease: regulation of RANTES (CCL5) in renal disease.Diagnostic potential for urinary proteomics.High-throughput antibody microarrays for quantitative proteomic analysis.Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseasesPreclinical perspective of urinary biomarkers for the detection of nephrotoxicity: what we know and what we need to know.Discovering cancer biomarkers from clinical samples by protein microarrays.Tumor necrosis factor-α regulates matrix metalloproteinase-2 expression and cell migration via ERK pathway in rat glomerular mesangial cells.Urinary Biomarkers for Chronic Kidney Disease with a Focus on Gene TranscriptSelected renal cells modulate disease progression in rodent models of chronic kidney disease via NF-κB and TGF-β1 pathways.A population of selected renal cells augments renal function and extends survival in the ZSF1 model of progressive diabetic nephropathy.Neuroproteomics Studies: Challenges and Updates.Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy.Increased Matrix Metalloproteinase 2 Activity in the Human Internal Mammary Artery Is Associated with Ageing, Hypertension, Diabetes and Kidney Dysfunction
P2860
Q33917932-1191002E-5BA0-46AF-893C-B869FFBAA7F9Q34026590-858E36AC-2FB5-4EFE-8B85-2D0DBB14CE1BQ35819489-FAE1435B-BC9A-4340-A89A-F10192F7AFD4Q35903082-B2CE99F3-B407-48F2-A548-39B697E6ED78Q36739752-137BF910-A174-41A7-A970-0EB7591B60F3Q36745404-70FF774E-4CAA-411F-863E-851B2946B492Q36745677-63836417-5D0B-4270-BE39-B7B4BA99FE86Q36913048-0934F90B-FA9A-4AE2-9DA5-48AF5830CEA5Q37107248-AC558A69-6B15-453F-92BA-F1F6376E31BBQ37959015-73CF8D79-2D67-436B-846E-161CEA5EE793Q38293886-F011D666-1E17-40FD-A332-C03505D8F0B1Q38997755-E8FA7FFB-D6CD-4B61-BA5E-74A8E6703C25Q41097627-BEACE3D1-309F-4E4F-B77C-46B162D9D45FQ45880706-95BBD1BE-8099-4E4A-89B3-DABB5DA4D559Q46182549-75C1FCD2-5D95-4A1F-BEDD-40570E23C07CQ47721773-33BDADDD-8851-42EC-B984-8BDA631AD36DQ54355169-EE3F729F-3BB8-4995-B1D0-97E143A4D0E3Q57913958-0DA28FEF-A10B-4BD8-9326-240901362367
P2860
Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Application of antibody array ...... s with chronic kidney disease.
@en
Application of antibody array ...... s with chronic kidney disease.
@nl
type
label
Application of antibody array ...... s with chronic kidney disease.
@en
Application of antibody array ...... s with chronic kidney disease.
@nl
prefLabel
Application of antibody array ...... s with chronic kidney disease.
@en
Application of antibody array ...... s with chronic kidney disease.
@nl
P2093
P2860
P356
P1476
Application of antibody array ...... s with chronic kidney disease.
@en
P2093
Bi-Cheng Liu
Dian-ge Liu
Xiao-liang Zhang
Yan-li Wang
P2860
P304
P356
10.1159/000096871
P577
2006-11-07T00:00:00Z